IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 21 May 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00015-07v1
75/8/3848    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leduc, D.
Right arrow Articles by Pidard, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leduc, D.
Right arrow Articles by Pidard, D.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00015-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor (uPAR, CD87) through domain-specific endoproteolysis

Dominique Leduc, Nathalie Beaufort, Sophie de Bentzmann, Jean-Claude Rousselle, Abdelkader Namane, Michel Chignard, and Dominique Pidard*

Inserm, U874, Paris, F-75015 France; Inst Pasteur, Unité de Défense Innée et Inflammation, Paris, F-75015 France; CNRS, IBSM-UPR9027, Marseille, F-13402 France; Inst Pasteur, Plate-Forme de Protéomique, Paris, F-75015 France

* To whom correspondence should be addressed. Email: pidard{at}bichat.inserm.fr.


   Abstract

Pseudomonas aeruginosa is an opportunistic pathogen in human lungs, where its secretable LasB metalloproteinase can be a virulence factor. The urokinase receptor (uPAR) participates in pericellular proteolysis and adherence/migration of epithelial cells and leukocytes recruited during infection, and shows functional regulation by various proteinases via limited endoproteolysis occuring within its three domains (D1 to D3). We thus examined proteolytic activity of LasB on uPAR, using a recombinant uPAR as well as uPAR-expressing, human monocytic and bronchial epithelial cell lines. Protein immunoblotting and flow immunocytometry using a panel of domain-specific anti-uPAR antibodies, showed that LasB is able to cleave uPAR both within the sequence linking D1 to D2, and at the carboxyterminus of D3. Comparison of LasB-producing and LasB-deficient bacterial strains indicated that LasB is entirely responsible for the uPAR cleavage ability of P. aeruginosa. Based on aminoterminal protein microsequencing, and mass spectrometry analysis of the cleavage of peptides mimicking the uPAR sequences targeted by LasB, cleavage sites were determined to be Ala84-Val85 and Thr86-Tyr87 (D1-D2), and Gln279-Tyr280 (D3). Such a dual cleavage of uPAR led to both removal of aminoterminal D1 and generation of truncated D2D3 species, and shedding of D2D3 from cells. This proteolytic processing of uPAR was found to (i) drastically reduce the capacity of cells to bind urokinase, and (ii) abrogate the interaction between uPAR and the matrix adhesive protein vitronectin. The LasB proteinase is thus endowed with a high potential for alteration of uPAR expression and functioning on inflammatory cells during infections by P. aeruginosa.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.